Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to -$350000.0.

  • Rallybio's Change in Accured Expenses rose 8932.6% to -$350000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 238.82%. This contributed to the annual value of -$3.3 million for FY2024, which is 13173.94% down from last year.
  • Rallybio's Change in Accured Expenses amounted to -$350000.0 in Q3 2025, which was up 8932.6% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Rallybio's Change in Accured Expenses ranged from a high of $1.6 million in Q2 2025 and a low of -$3.6 million during Q1 2023
  • Over the past 3 years, Rallybio's median Change in Accured Expenses value was -$350000.0 (recorded in 2025), while the average stood at -$542636.4.
  • In the last 5 years, Rallybio's Change in Accured Expenses crashed by 31600.79% in 2024 and then soared by 279642.86% in 2025.
  • Quarter analysis of 3 years shows Rallybio's Change in Accured Expenses stood at -$687000.0 in 2023, then tumbled by 102.77% to -$1.4 million in 2024, then soared by 74.87% to -$350000.0 in 2025.
  • Its Change in Accured Expenses was -$350000.0 in Q3 2025, compared to $1.6 million in Q2 2025 and -$2.5 million in Q1 2025.